Linagliptin + metformin

COMBINATION_PRODUCT3 trials

Sponsors

Boehringer Ingelheim, Universidad de Guanajuato

Conditions

Diabetes Mellitus, Type 2Insulin ResistancePrediabetic State

Phase 3

Treatment of Type 2 Diabetes With Linagliptin 2.5 mg Bid + Metformin 500 or 1000 mg Bid and Metformin 1000 mg Bid

CompletedNCT00915772

Boehringer IngelheimDiabetes Mellitus, Type 2

Start: 2009-06-30Updated: 2014-05-14

Effect of Low Dose Combination of Linagliptin + Metformin to Prevent Diabetes

Universidad de GuanajuatoInsulin Resistance, Prediabetic State

Start: 2019-09-01End: 2020-07-01Target: 34Updated: 2019-10-25

Phase 4

Effect of Linagliptin + Metformin vs Metformin Alone in Patients With Prediabetes

CompletedNCT03004612

Universidad de GuanajuatoInsulin Resistance, Prediabetic State

Start: 2016-01-31End: 2019-06-30Updated: 2019-07-09